Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment by York E. Miller, York E. Miller, Moumita Ghosh, Daniel T. Merrick, Brandi Kubala, Eva Szabo, Lisa Bengtson, Masha Kocherginsky, Irene B. Helenowski, Kelly Benante, Tia Schering, Jihye Kim, Hyunmin Kim, Duc Ha, Raymond C. Bergan, Seema A. Khan, Robert L. Keith, Robert L. Keith

Get full text